Skip to content
OpenCapital
Get started

Achieve Life Sciences ACHV Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate at other companies

Belden logo
BeldenBDC
4%-0.4pp
KEE
Keel Infrastructure Corp. Common StockKEEL
3.7%-0.8pp
Norwood Financial logo
Norwood FinancialNWFL
4.1%-0.3pp
CHE
ChemedCHE
3.5%-0.5pp
Capital City Bank Group logo
Capital City Bank GroupCCBG
3.9%-0.9pp
RBC Bearings logo
RBC BearingsRBC
3.9%0.0pp

Other financials

Income statement

See full
Net income-$10.2M+20.7%
EPS (diluted)-$0.19+48.6%

Balance sheet

See full
Cash & equivalents$28.1M+116%
Total debt$5.6M+332%
Total equity$10.7M+3.9%
Total assets$33.1M+21.0%

Cash flow

See full
Operating cash flow-$6.9M+37.5%
CapEx$750.0—
Free cash flow-$12.4M—

Valuation

See full
Market cap$585.16M+404%
Enterprise value$562.71M+439%

Returns & leverage

See full
Return on equity-496.1%-906pp
Debt / equity0.5×+0.4×
Current ratio2.6×-0.9×

Where this comes from

Reported directly by Achieve Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate.

The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's share based compensation arrangement by share based payment award fair value assumptions risk free interest rate.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Achieve Life Sciences's share based compensation arrangement by share based payment award fair value assumptions risk free interest rate?
Achieve Life Sciences (ACHV) reported share based compensation arrangement by share based payment award fair value assumptions risk free interest rate of 3.9% in Q1 2026.
How has Achieve Life Sciences's share based compensation arrangement by share based payment award fair value assumptions risk free interest rate changed year-over-year?
Achieve Life Sciences's share based compensation arrangement by share based payment award fair value assumptions risk free interest rate decreased by 14.8% year-over-year, from 4.6% to 3.9%.
What does share based compensation arrangement by share based payment award fair value assumptions risk free interest rate mean?
The risk-free interest rate used as an input in valuation models to determine the fair value of share-based payment awards. It reflects the market-based assumption for the time value of money over the expected term of the awards.